METHOD OF DIAGNOSTICS OF LIVER STEATOSIS Russian patent published in 2018 - IPC A61B5/00 A61B8/00 G01N33/48 

FIELD: medicine.

SUBSTANCE: invention relates to medicine and can be used to diagnose hepatic steatosis. Height, weight, body mass index of a patient are measured. Presence of diabetes mellitus (DM), arterial hypertension (AH), metabolic syndrome (MS), alcoholic liver disease (ALD) is checked. Fact and timing of taking systemic glucocorticosteroids is clarified. Blood levels of glycated hemoglobin (HbA1c), alanine aminotransferase (ALT), aspartate aminotransferase (ACT), gamma-glutamyltranspeptidase (GGT), alkaline phosphatase (APh), total bilirubin, direct bilirubin and cholesterol are determined. Then, ultrasound inspection of the liver is performed and the ultrasonic wave attenuation factor is determined (dB/cm). Received data are evaluated in points. Liver steatosis is determined by the sum of the points: 0 points – no steatosis; 1–3 points – minimal liver steatosis; 4–9 points – moderate liver steatosis; more than 10 points – pronounced liver steatosis.

EFFECT: method allows to accurately and non-invasively conduct a diagnostics of liver steatosis by evaluating the complex of the most significant indicators.

1 cl, 1 tbl, 4 ex